CSIMarket
 
Enzo Biochem Inc  (NYSE: ENZ)
 

Enzo Biochem Inc's Customers Performance

ENZ



 
ENZ's Source of Revenues During the corresponding time, Enzo Biochem Inc saw a revenue deteriorated by -20.19 % year on year, sequentially revenue fell by -12.71 %. While revenue at the Enzo Biochem Inc's corporate clients

• List of ENZ Customers




for the same period Enzo Biochem Inc revnue deteriorated by -20.19 % year on year, sequentially revenue fell by -12.71 %.

• List of ENZ Customers

Enzo Biochem Inc's Business Units






Enzo Biochem Inc's Comment on Sales, Marketing and Customers



Enzo Life Sciences provides products and services to the life sciences sector, supporting research, drug discovery and development, and diagnostic applications. Its customers include basic researchers, drug developers, and clinical researchers worldwide. The company focuses on research areas such as genomics, cell biology, and biomarker detection, as well as applied research markets including spatial biology, cell and gene therapy, bioprocessing, personal care, cancer research, and neuroscience. Enzo Life Sciences operates globally through wholly owned subsidiaries and a network of distributors, offering sales and technical support in local languages. Its market comprises biomedical and pharmaceutical companies requiring research and diagnostic tools for gene- and protein-targeted diagnostics, utilizing instruments such as DNA sequencing equipment, microarrays, fluorescent microscopes, and flow cytometers.





Enzo Biochem Inc’s Comment on Sales, Marketing and Customers


Enzo Life Sciences provides products and services to the life sciences sector, supporting research, drug discovery and development, and diagnostic applications. Its customers include basic researchers, drug developers, and clinical researchers worldwide. The company focuses on research areas such as genomics, cell biology, and biomarker detection, as well as applied research markets including spatial biology, cell and gene therapy, bioprocessing, personal care, cancer research, and neuroscience. Enzo Life Sciences operates globally through wholly owned subsidiaries and a network of distributors, offering sales and technical support in local languages. Its market comprises biomedical and pharmaceutical companies requiring research and diagnostic tools for gene- and protein-targeted diagnostics, utilizing instruments such as DNA sequencing equipment, microarrays, fluorescent microscopes, and flow cytometers.








ENZ's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Enzo Biochem Inc 17.61 27.48 -21.08 401
SUBTOTAL 0.00 0.00 0.00 -

Sources: Enzo Biochem Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Enzo Biochem Inc’s corporate clients.
For your research, we’ve provided 9 tables on Enzo Biochem Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.